论文部分内容阅读
目的探讨米非司酮配伍米索前列醇终止瘢痕子宫中期妊娠的临床效果。方法选择自愿终止妊娠患者83例,将以上患者随机分为两组,观察组和对照组。对照组患者进行羊膜腔内注射利凡诺尔100mg进行引产。观察组给予米非司酮和米索前列醇进行引产。观察两组患者总产程时间、引产后的出血量、完全流产率、引产成功率。结果观察组总产程时间、引产后的出血量、完全流产率与对照组比较,差异有统计学意义(P<0.05)。结论米非司酮配伍米索前列醇终止瘢痕子宫中期妊娠效果显著,值得借鉴。
Objective To investigate the clinical efficacy of mifepristone combined with misoprostol in terminating scar pregnancy. Methods Eighty-three patients with voluntary termination of pregnancy were selected and randomized into two groups: observation group and control group. Patients in the control group received rivanol 100 mg intra-amniotic injection for induction of labor. The observation group was given mifepristone and misoprostol for induction of labor. The total duration of labor, the amount of bleeding after induction of labor, the rate of complete abortion and the success rate of induction of labor were observed. Results The total duration of labor, the amount of bleeding after induced labor and the rate of complete abortion in the observation group were significantly different from those in the control group (P <0.05). Conclusion Mifepristone with misoprostol termination of hypertrophic scar pregnancy is significant, it is worth learning.